Copytele Inc Stock OTC Bulletin Board
Equities
COPY
US2177211099
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 18 | Anixa Biosciences Welcomes Sanjay Juneja to Its Cancer Business Advisory Board | CI |
Mar. 12 | Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 95.06M |
---|---|---|---|---|---|
Net income 2024 * | -14M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.77
x | P/E ratio 2025 * |
-6.62
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.1% |
Latest transcript on Copytele Inc
Managers | Title | Age | Since |
---|---|---|---|
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Michael Catelani
DFI | Director of Finance/CFO | 57 | 16-10-31 |
Pamela Garzone
PRN | Corporate Officer/Principal | 69 | 21-09-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Titterton
BRD | Director/Board Member | 79 | 99-06-30 |
Amit Kumar
CEO | Chief Executive Officer | 59 | 12-10-31 |
Emily Gottschalk
BRD | Director/Board Member | 63 | 19-10-22 |
1st Jan change | Capi. | |
---|---|---|
+2.03% | 42.59B | |
+7.33% | 40.65B | |
+49.22% | 40.57B | |
-11.96% | 26.77B | |
+9.22% | 24.81B | |
-24.03% | 18.17B | |
+27.38% | 12.05B | |
-3.09% | 11.7B | |
+7.05% | 11.1B |
- Stock Market
- Equities
- ANIX Stock
- COPY Stock